Literature DB >> 10219443

Endoscopic sphenopalatine artery ligation is an effective method of treatment for posterior epistaxis.

C H Snyderman1, S A Goldman, R L Carrau, B J Ferguson, J R Grandis.   

Abstract

Transantral ligation of the internal maxillary artery is the most widely used surgical technique for control of intractable epistaxis. Although this technique is highly efficacious, significant complications may occur, including oroantral fistula, damage to the infraorbital nerve, and recurrent bleeding. An endoscopic transnasal approach for ligation of the terminal branch of the internal maxillary artery, the sphenopalatine artery, provides an alternative to transantral ligation. We have used endoscopic ligation of the sphenopalatine artery to treat 38 patients requiring surgical therapy for epistaxis. These cases were retrospectively reviewed to analyze the efficacy and morbidity of our technique. Five patients (13%) had significant recurrence of their epistaxis, of whom two required further surgical intervention. There were no major complications in this series. There were some minor sequelae including nasal crusting (34%) and paresthesia of the palate and nose (13%). The median hospital stay was 3 days (range 1 to 10). Endoscopic transnasal sphenopalatine artery ligation seems to be a safe and effective technique for management of posterior epistaxis.

Entities:  

Mesh:

Year:  1999        PMID: 10219443     DOI: 10.2500/105065899782106805

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  15 in total

1.  Posterior epistaxis: endonasal exposure and occlusion of the branches of the sphenopalatine artery.

Authors:  David Holzmann; Thomas Kaufmann; Paula Pedrini; Anton Valavanis
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-04-29       Impact factor: 2.503

Review 2.  Comprehensive review on endonasal endoscopic sinus surgery.

Authors:  Rainer K Weber; Werner Hosemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

3.  The nasal seromucinous glands after endoscopic sphenopalatine artery coagulation.

Authors:  Samy Elwany; Ayman Moustafa Al-Medany; Hoda Mahmoud Khalifa; Sedik Abdel Salam; Ahmed Soliman; Osama Abu el-Kheir
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-02-19       Impact factor: 2.503

4.  Surgical anatomy of the sphenopalatine foramen and its arterial content.

Authors:  J M Prades; A Asanau; A P Timoshenko; M B Faye; Ch Martin
Journal:  Surg Radiol Anat       Date:  2008-07-23       Impact factor: 1.246

5.  Endoscopic identification of the pharyngeal (palatovaginal) canal: an overlooked area.

Authors:  Islam R Herzallah; Sameh Amin; Mona A El-Hariri; Roy R Casiano
Journal:  J Neurol Surg B Skull Base       Date:  2012-10

6.  Anatomical and surgical study of the sphenopalatine artery branches.

Authors:  Juan R Gras-Cabrerizo; Joan M Ademá-Alcover; Juan R Gras-Albert; Katarzyna Kolanczak; Joan R Montserrat-Gili; Rosa Mirapeix-Lucas; Francisco Sanchez Del Campo; Humbert Massegur-Solench
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-20       Impact factor: 2.503

Review 7.  The expanding role of interventional radiology in head and neck surgery.

Authors:  Stephen Broomfield; Iain Bruce; Andrew Birzgalis; Amit Herwadkar
Journal:  J R Soc Med       Date:  2009-06       Impact factor: 5.344

8.  An image-guided (CT) assessment of a new asymmetric balloon for the treatment of epistaxis.

Authors:  Guillaume Trau; Aina Venkatasamy; Idir Djennaoui; Marion Renaud; Léa Fath; Saït Ciftci
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-03-23       Impact factor: 2.503

Review 9.  Management of intractable spontaneous epistaxis.

Authors:  Luke Rudmik; Timothy L Smith
Journal:  Am J Rhinol Allergy       Date:  2012 Jan-Feb       Impact factor: 2.467

10.  The Wexham Criteria: defining severe epistaxis to select patients requiring sphenopalatine artery ligation.

Authors:  Raj Lakhani; Irfan Syed; Ali Qureishi; Nigel Bleach
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-20       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.